by Proxiva Peptides | Mar 5, 2026 | Research Guides
The Two Giants of GLP-1 Weight Loss Research Tirzepatide and semaglutide are the most effective anti-obesity peptides ever developed, each producing weight loss that was considered impossible with pharmacotherapy just a decade ago. But while both target the GLP-1...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
Understanding the Distinction The terms “natural” and “synthetic” are widely used in peptide discussions, but their meaning is more nuanced than it might appear. Natural peptides are produced by living organisms through ribosomal translation or...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
Two Very Different Peptides BPC-157 and collagen peptides are both referred to as “peptides,” but they could hardly be more different in their mechanisms, applications, and evidence base. BPC-157 is a 15-amino-acid signaling peptide that triggers tissue...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
Two Approaches to Regeneration Regenerative medicine aims to repair, replace, or regenerate damaged tissues and organs. Two of the most promising tools in this field are bioactive peptides and stem cells — each offering distinct mechanisms, advantages, and...
by Proxiva Peptides | Mar 5, 2026 | Research Guides
Two Pillars of Metabolic Research Semaglutide and metformin represent two fundamentally different approaches to metabolic intervention — one a cutting-edge peptide GLP-1 receptor agonist, the other a decades-old small molecule that remains the most prescribed diabetes...
